[Baricitinib (rheumatoid arthritis) - Addendum to commission A17-14]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003307
Original Title: Baricitinib (rheumatoide Arthritis) - Addendum zum Auftrag A17-14
Project Status: Completed
Year Published: 2017
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Arthritis, Rheumatoid
  • Janus Kinase Inhibitors
  • Antirheumatic Agents
  • Azetidines
  • Pyrazoles
  • Purines
  • Sulfonamides
  • Baricitinib
  • Arthritis - Rheumatoid
  • Benefit Assessment
  • NCT01710358
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.